Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

This FDA vote was personal

Committee member who recommended biosimilar had own experience with costly drugs.

Talk about first hand knowledge.

The Washington Post's Wonkblog recently profiled Randy Hillard.

The Michigan State University psychiatry professor was diagnosed with stage four stomach cancer in 2010, and given less than a year to live.

But, for four years a once-every-three-weeks infusion of Herceptin, a breast cancer drug approved to treat some types of stomach cancer, has kept in him alive – at the tune of $1 million, with about $100,000 of it being paid for himself.

“I can barely afford that, and I’m a doctor,” he told them.

Hillard, however, is also a member of the FDA committee that recently recommended approval of the what could be the U.S' first biosimilar. Biosimilars are basically generic versions of biologics.

“Really, truly, we are betting our lives on these new biosimilars,” Hillard said.

As the blog post points out, the U.S. has had generic versions of drugs for years, making the cost to consumers lower. But, if the FDA takes the committees recommendation and approves the country's first biosimilar, it will open up a whole new category of lower-cost drugs to patients.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report